GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Accounts Payable & Accrued Expense

ACME Laboratories (DHA:ACMELAB) Accounts Payable & Accrued Expense : BDT490 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Accounts Payable & Accrued Expense?

ACME Laboratories's quarterly accounts payable & accrued expense declined from Jun. 2023 (BDT741 Mil) to Sep. 2023 (BDT525 Mil) and declined from Sep. 2023 (BDT525 Mil) to Mar. 2024 (BDT490 Mil).

ACME Laboratories's annual accounts payable & accrued expense increased from Jun. 2021 (BDT602 Mil) to Jun. 2022 (BDT715 Mil) and increased from Jun. 2022 (BDT715 Mil) to Jun. 2023 (BDT741 Mil).

ACME Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for ACME Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Accounts Payable & Accrued Expense Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 344.37 562.03 601.80 715.05 741.32

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,041.41 540.31 741.32 525.02 489.73

ACME Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ACME Laboratories (DHA:ACMELAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
DHA:ORIONINFU DHA:AFCAGRO DHA:BEACONPHAR DHA:BXPHARMA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085
Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
Website
https://www.acmeglobal.com
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines